Genistein - A Broad-spectrum Bioactive Compound with Diverse Pharmacological Potential: A Systematic Review

Area of Science:

• Pharmacology
• Biochemistry
• Drug Discovery

Background:

• Genistein is an isoflavone derived from soybeans and Dyer's broom.
• Its pharmacological potential is supported by extensive preclinical research.
• Genistein interacts with multiple cellular receptors and signaling pathways.

Purpose of the Study:

• To analyze the pharmaceutical profile of genistein using PASS software.
• To correlate genistein's efficacy with existing literature.
• To evaluate genistein's potential as a lead compound for various diseases.

Main Methods:

• Literature review and correlation with existing data.
• Analysis using PASS (Potential of anticancer drugs) software.
• Evaluation of genistein's efficacy against cancer, cardiovascular, neurodegenerative, and viral diseases.

Main Results:

• Genistein demonstrates broad-spectrum activity, including anticancer, cardioprotective, neuroprotective, and antiviral effects.
• Effective against breast, prostate, and lung cancers; Alzheimer's and Parkinson's diseases; and viral infections like HSV, HIV, and HPV.
• Shows promise in improving endothelial function, lowering cholesterol, and treating cardiac dysfunction and atherosclerosis.

Conclusions:

• Genistein is a versatile therapeutic agent with potential in oncology, cardiovascular health, and neurodegenerative therapies.
• Its broad pharmacological spectrum is promising for drug development.
• Suboptimal pharmacokinetics, including poor bioavailability, hinder clinical efficacy.